[HTML][HTML] The FDA and safe use of long-acting beta-agonists in the treatment of asthma

BA Chowdhury, G Dal Pan - New England Journal of Medicine, 2010 - Mass Medical Soc
BA Chowdhury, G Dal Pan
New England Journal of Medicine, 2010Mass Medical Soc
The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma | NEJM Skip to
main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare
to become a physician, build your knowledge, lead a health care organization, and advance
your career with NEJM Group information and services. NEJM Evidence NEW! A digital journal
for innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
The FDA has conducted a comprehensive review of the benefits and risks of using LABAs to treat asthma. Drs. Badrul Chowdhury and Gerald Dal Pan discuss the agency's conclusions.
The New England Journal Of Medicine